Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998051310) A METHOD FOR THE TREATMENT OF MENTAL ILLNESS IN MAMMALS AND A COMPOSITION THEREFOR
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/051310 International Application No.: PCT/FI1998/000398
Publication Date: 19.11.1998 International Filing Date: 11.05.1998
Chapter 2 Demand Filed: 09.12.1998
IPC:
A61K 31/4164 (2006.01) ,A61K 45/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants:
HAAPALINNA, Antti [FI/FI]; FI
VIITAMAA, Timo [FI/FI]; FI
SALLINEN, Jukka [FI/FI]; FI
SCHEININ, Mika [FI/FI]; FI
SAVOLA, Juha-Matti [FI/FI]; FI
Inventors:
HAAPALINNA, Antti; FI
VIITAMAA, Timo; FI
SALLINEN, Jukka; FI
SCHEININ, Mika; FI
SAVOLA, Juha-Matti; FI
Agent:
ORION CORPORATION; Orion Pharma Industrial Property Rights P.O. Box 65 FIN-02101 Espoo, FI
Priority Data:
08/854,73012.05.1997US
Title (EN) A METHOD FOR THE TREATMENT OF MENTAL ILLNESS IN MAMMALS AND A COMPOSITION THEREFOR
(FR) PROCEDE DE TRAITEMENT DE MALADIE MENTALE CHEZ LES MAMMIFERES ET COMPOSITION A CET EFFET
Abstract:
(EN) The invention relates to a method for treating a mammal suffering from mental illness induced by propagation of stress, said method comprising the step of removing or diminishing the tone of the endogenous alpha-2C-adrenoceptors in the central nervous system of said mammal. The invention relates further to pharmaceutical compositions useful for said treatment.
(FR) Cette invention concerne un procédé de traitement d'un mammifère qui souffre d'une maladie mentale induite par la propagation de tensions nerveuses. Ce procédé consiste à éliminer ou diminuer la tonalité des alpha-2C-adrénocepteurs endogènes dans le système nerveux central dudit mammifère. Cette invention concerne également des compositions pharmaceutiques utilisés dans ce traitement.
Designated States: AL, AM, AT, AU, AZ, BA, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, ID, IL, IS, JP, KG, KR, KZ, LT, LU, LV, MD, MK, MN, MX, NO, NZ, PL, PT, RO, RU, SE, SG, SI, SK, TJ, TM, TR, UA, US, UZ, YU
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CZPV1999-3948NO19995469SK154199MXPA/a/1999/010411EP1003518JP2001524979
CA2288650AU1998074334